Search

everythinglearnresearchcommunity

for

Search:↓

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Long COVID care improved the patient's mobility, breathing, anxiety, and social relationships.

COVID-19 vaccination is generally safe for people with Hidradenitis Suppurativa.

Understanding and managing long-term COVID-19 effects is crucial.

Shi-Bi-Man helps hair regrowth by activating the FGF pathway in cells.

COVID-19 affects multiple body systems and complicates treatment; accurate testing is crucial.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

COVID-19 can cause skin problems in children.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

COVID-19 severely affects older adults with chronic heart, lung, or metabolic diseases.

Certain immune responses may cause ongoing COVID-19 symptoms like fatigue and brain fog.

Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

COVID-19 vaccination may trigger lupus in some people.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Neuropathic pain is common in long COVID patients, especially those with depression or severe COVID-19.

Damaged skin has a weakened barrier, making it more vulnerable to substances and inflammation.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

COVID-19 can cause various skin symptoms, including rashes and lesions, which often appear early and can help in timely diagnosis.

COVID-19 may cause a common type of hair loss called telogen effluvium.

COVID-19 can cause various skin symptoms, with different patterns seen in younger and older patients.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Long COVID causes lasting symptoms and needs vaccines for prevention and a team approach for treatment.

TMPRSS2 affects COVID-19 severity and treatment options.